-
1
-
-
0026740158
-
Transplant coronary artery disease: non immunologic risk factors
-
Johnson M. Transplant coronary artery disease: non immunologic risk factors. J Heart Lung Transplant 11 S124 (1992) 32
-
(1992)
J Heart Lung Transplant
, vol.11
, Issue.SUPPL.124
, pp. 32
-
-
Johnson, M.1
-
2
-
-
0343410759
-
The Australian Cardiothoracic Organ Transplant Registry: first report 1984-1992
-
Keogh A., and Kaan A. The Australian Cardiothoracic Organ Transplant Registry: first report 1984-1992. Aust N Z J Med 22 (1992) 712
-
(1992)
Aust N Z J Med
, vol.22
, pp. 712
-
-
Keogh, A.1
Kaan, A.2
-
4
-
-
0029119711
-
Effect of pravastatin on outcomes after cardiac transplantation
-
Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621
-
(1995)
N Engl J Med
, vol.333
, pp. 621
-
-
Kobashigawa, J.A.1
Katznelson, S.2
Laks, H.3
-
5
-
-
0031654546
-
Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database
-
Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 17 (1998) 744
-
(1998)
J Heart Lung Transplant
, vol.17
, pp. 744
-
-
Costanzo, M.R.1
Naftel, D.C.2
Pritzker, M.R.3
-
6
-
-
0029161742
-
Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy
-
McManus B.M., Horley K.J., Wilson J.E., et al. Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. Am J Pathol 147 (1995) 293
-
(1995)
Am J Pathol
, vol.147
, pp. 293
-
-
McManus, B.M.1
Horley, K.J.2
Wilson, J.E.3
-
7
-
-
0033877290
-
Role of statins in the management of dyslipidemia after cardiac transplant: randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin
-
Magnani G., Carinci V., Magelli C., et al. Role of statins in the management of dyslipidemia after cardiac transplant: randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin. J Heart Lung Transplant 19 (2000) 710
-
(2000)
J Heart Lung Transplant
, vol.19
, pp. 710
-
-
Magnani, G.1
Carinci, V.2
Magelli, C.3
-
8
-
-
0037422562
-
Simvastatin initiated early after heart transplantation: 8-year prospective experience
-
Wenke K., Meiser B., Thiery J., et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 107 (2003) 93
-
(2003)
Circulation
, vol.107
, pp. 93
-
-
Wenke, K.1
Meiser, B.2
Thiery, J.3
-
9
-
-
0025200422
-
Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2
-
Cutts J.L., and Bankhurst A.D. Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2. J Cell Physiol 145 (1990) 244
-
(1990)
J Cell Physiol
, vol.145
, pp. 244
-
-
Cutts, J.L.1
Bankhurst, A.D.2
-
10
-
-
0023839115
-
Myolisis and acute renal failure in a heart transplant recipent receiving lovastatin
-
(letter)
-
Norman D.J., Illingworth D.R., Munson J., et al. Myolisis and acute renal failure in a heart transplant recipent receiving lovastatin. (letter). N Engl J Med 318 (1988) 46
-
(1988)
N Engl J Med
, vol.318
, pp. 46
-
-
Norman, D.J.1
Illingworth, D.R.2
Munson, J.3
-
11
-
-
29544433421
-
Safety of statins when response is carefully monitored: a study of 336 heart recipients
-
Marzoa-Rivas R., Crespo-Leiro M.G., Paniaguna-Marin M.J., et al. Safety of statins when response is carefully monitored: a study of 336 heart recipients. Transplant Proc 37 (2005) 4071
-
(2005)
Transplant Proc
, vol.37
, pp. 4071
-
-
Marzoa-Rivas, R.1
Crespo-Leiro, M.G.2
Paniaguna-Marin, M.J.3
-
12
-
-
33847375619
-
Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients
-
Patel A.R., Ambrose M.S., Doffy G.A., et al. Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients. J Heart Lung Transplant 26 (2007) 281
-
(2007)
J Heart Lung Transplant
, vol.26
, pp. 281
-
-
Patel, A.R.1
Ambrose, M.S.2
Doffy, G.A.3
-
13
-
-
19544371758
-
Ezetimibe: a review of it's metabolism, pharmacokinetics, and drug interactions
-
Kosoglou T., Statkevich P., Johnson Levonas A.J., et al. Ezetimibe: a review of it's metabolism, pharmacokinetics, and drug interactions. Clin Pharmacokinet 44 (2005) 467
-
(2005)
Clin Pharmacokinet
, vol.44
, pp. 467
-
-
Kosoglou, T.1
Statkevich, P.2
Johnson Levonas, A.J.3
-
14
-
-
0033930458
-
Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients
-
Chin C., Rosenthal D., and Bernstein D. Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients. Pediatr Transplant 4 (2000) 193
-
(2000)
Pediatr Transplant
, vol.4
, pp. 193
-
-
Chin, C.1
Rosenthal, D.2
Bernstein, D.3
-
15
-
-
0036845850
-
Efficacy and safety of atorvastatin after pediatric heart transplantation
-
Chin C., Gamberg P., Miller J., et al. Efficacy and safety of atorvastatin after pediatric heart transplantation. J Heart Lung Transplant 21 (2002) 1213
-
(2002)
J Heart Lung Transplant
, vol.21
, pp. 1213
-
-
Chin, C.1
Gamberg, P.2
Miller, J.3
-
16
-
-
11844286845
-
Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation
-
Mahle W.T., Vincent R.N., Berg A.M., et al. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation. J Heart Lung Transplant 24 (2005) 63
-
(2005)
J Heart Lung Transplant
, vol.24
, pp. 63
-
-
Mahle, W.T.1
Vincent, R.N.2
Berg, A.M.3
|